Due to the described evidence of TNF-α implication in pancreatic cancer progression, Egberts and his group investigated the effects of the chimeric monoclonal antibodies infliximab and etanercept on PDAC cells in both in vitro and in vivo models. This evidence concerns the gene TNF and familial pancreatic carcinoma.